Gain Therapeutics, Inc.

8-K Other events Jul 16, 2026 8-K Other events Jun 29, 2026 8-K Shareholder vote results Jun 25, 2026 8-K Other events May 26, 2026 10-Q Quarter ended 2026-03-31 May 11, 2026 8-K Results of operations (earnings release) May 11, 2026 10-K Fiscal year ended 2025-12-31 Mar 26, 2026 8-K Results of operations (earnings release) Mar 26, 2026 8-K Regulation FD disclosure; Other events Mar 18, 2026 8-K Regulation FD disclosure Feb 3, 2026 8-K Other events Dec 18, 2025 8-K Other events Nov 28, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Results of operations (earnings release) Nov 12, 2025 8-K Regulation FD disclosure Oct 14, 2025 8-K Director or officer change Oct 9, 2025 8-K Other events Oct 6, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Results of operations (earnings release) Aug 12, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Jul 17, 2025 8-K Other events Jun 30, 2025 8-K Amended charter or bylaws; Shareholder vote results Jun 24, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Results of operations (earnings release) May 14, 2025 8-K Regulation FD disclosure; Other events Apr 10, 2025 10-K Fiscal year ended 2024-12-31 Mar 27, 2025 8-K Results of operations (earnings release) Mar 27, 2025 8-K Regulation FD disclosure Feb 6, 2025 8-K Delisting notice or listing-rule failure Jan 15, 2025 8-K Director or officer change; Regulation FD disclosure Jan 7, 2025 8-K Regulation FD disclosure; Other events Dec 23, 2024 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Results of operations (earnings release) Nov 14, 2024 8-K Other events Oct 21, 2024 8-K Regulation FD disclosure; Other events Oct 8, 2024 8-K Entered a material agreement Sep 6, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release) Aug 8, 2024 8-K Delisting notice or listing-rule failure Jul 12, 2024 8-K Regulation FD disclosure; Other events Jul 9, 2024